Gardasil 9 (HPV)

Frequently Asked Questions

1. What is HPV?

Human papillomavirus (HPV) is a very common virus spread through intimate skin-to-skin contact. Some HPV types can lead to cancer or genital warts.

2. What does Gardasil 9 protect against?

Gardasil 9 protects against nine HPV types associated with cervical cancer, other HPV-related cancers, and genital warts.

3. Who should receive the HPV vaccine?

HPV vaccination is recommended for both males and females. It is funded in New Zealand for eligible people aged 9 to 26 years.

4. How many doses will I need?

The number of doses depends on your age when vaccination begins. Younger individuals typically require two doses, while those starting later generally require three doses.

5. Can adults still get the HPV vaccine?

Yes. Gardasil 9 is licensed in New Zealand for people up to 45 years of age, although funding eligibility may vary.

6. Is the HPV vaccine safe?

Yes. Gardasil 9 has been extensively studied and is used worldwide. Common side effects are usually mild and may include soreness at the injection site, headache, or tiredness.

7. Can the HPV vaccine treat an existing HPV infection?

No. The vaccine helps prevent future HPV infections but does not treat existing HPV infections or HPV-related conditions.

8. Is cervical screening still important after vaccination?

Yes. HPV vaccination provides excellent protection, but regular cervical screening remains important for eligible individuals.